| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 87/11/24 | 97/07/16 | 李伊俐 | 李伊伶 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.07(Q2) | 0 | 2.06 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 1,986,188,790 | 198,618,879 | ||
| 主要經營業務 | |||
| 天然植物、中草藥成分、萃取分離技術、生化科技之研發中草藥、原料藥及化學藥品之研發醫藥品之顧問服務 | |||
| 公司網址 | |||
| phytohealth.com.tw | |||
懷特(4108) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 13,798 | 14,316 | 15.2% | -3.6% | 98,149 | 90,922 | 7.9% |
| 2023/07 | 11,981 | 8,752 | -22.3% | 36.9% | 84,351 | 76,606 | 10.1% |
| 2023/06 | 15,410 | 10,995 | 25.2% | 40.2% | 72,370 | 67,854 | 6.7% |
| 2023/05 | 12,307 | 11,031 | 5.3% | 11.6% | 56,960 | 56,859 | 0.2% |
| 2023/04 | 11,692 | 10,867 | -24.6% | 7.6% | 44,653 | 45,828 | -2.6% |
| 2023/03 | 15,513 | 14,352 | 78% | 8.1% | 32,961 | 34,961 | -5.7% |
| 2023/02 | 8,713 | 9,591 | -0.3% | -9.1% | 17,448 | 20,609 | -15.3% |
| 2023/01 | 8,735 | 11,018 | -18.5% | -20.7% | 8,735 | 11,018 | -20.7% |
| 2022/12 | 10,716 | 11,700 | -21% | -8.4% | 135,466 | 168,952 | -19.8% |
| 2022/11 | 13,567 | 11,568 | 42.3% | 17.3% | 124,750 | 157,252 | -20.7% |
| 2022/10 | 9,531 | 17,371 | -11.2% | -45.1% | 111,183 | 145,684 | -23.7% |
| 2022/09 | 10,730 | 11,506 | -25% | -6.7% | 101,652 | 128,313 | -20.8% |
| 2022/08 | 14,316 | 19,215 | 63.6% | -25.5% | 90,922 | 116,807 | -22.2% |
| 2022/07 | 8,752 | 17,208 | -20.4% | -49.1% | 76,606 | 97,592 | -21.5% |
| 2022/06 | 10,995 | 19,812 | -0.3% | -44.5% | 67,854 | 80,384 | -15.6% |
| 2022/05 | 11,031 | 16,292 | 1.5% | -32.3% | 56,859 | 60,572 | -6.1% |
| 2022/04 | 10,867 | 19,106 | -24.3% | -43.1% | 45,828 | 44,280 | 3.5% |
| 2022/03 | 14,352 | 9,348 | 49.6% | 53.5% | 34,961 | 25,174 | 38.9% |
| 2022/02 | 9,591 | 8,232 | -12.9% | 16.5% | 20,609 | 15,826 | 30.2% |
| 2022/01 | 11,018 | 7,594 | -5.8% | 45.1% | 11,018 | 7,594 | 45.1% |
| 2021/12 | 11,700 | 15,838 | 1.1% | -26.1% | 168,953 | 91,810 | 84% |
| 2021/11 | 11,569 | 8,157 | -33.4% | 41.8% | 157,253 | 75,972 | 107% |
| 2021/10 | 17,371 | 7,778 | 51% | 123.3% | 145,684 | 67,815 | 114.8% |
| 2021/09 | 11,506 | 7,156 | -40.1% | 60.8% | 128,313 | 60,037 | 113.7% |
| 2021/08 | 19,215 | 9,481 | 11.7% | 102.7% | 116,807 | 52,881 | 120.9% |
| 2021/07 | 17,208 | 6,977 | -13.1% | 146.6% | 97,592 | 43,400 | 124.9% |
| 2021/06 | 19,812 | 7,268 | 21.6% | 172.6% | 80,384 | 36,423 | 120.7% |
| 2021/05 | 16,292 | 10,347 | -14.7% | 57.5% | 60,572 | 29,155 | 107.8% |
| 2021/04 | 19,106 | 5,348 | 104.4% | 257.3% | 44,280 | 18,808 | 135.4% |
| 2021/03 | 9,348 | 6,790 | 13.6% | 37.7% | 25,174 | 13,460 | 87% |
| 2021/02 | 8,232 | 3,298 | 8.4% | 149.6% | 15,826 | 6,670 | 137.3% |
| 2021/01 | 7,594 | 3,372 | -52% | 125.2% | 7,594 | 3,372 | 125.2% |
| 2020/12 | 15,838 | 5,201 | 94.2% | 204.5% | 91,810 | 95,485 | -3.8% |
| 2020/11 | 8,157 | 4,447 | 4.9% | 83.4% | 75,972 | 90,284 | -15.9% |
| 2020/10 | 7,778 | 4,477 | 8.7% | 73.7% | 67,815 | 85,837 | -21% |
| 2020/09 | 7,156 | 4,734 | -24.5% | 51.2% | 60,037 | 81,360 | -26.2% |
寶利徠(1813) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 6.54% | -1.08% | 2020Q3 | 129.67% | 4.07% |
| 2023Q1 | 14.27% | -0.29% | 2020Q2 | -54.02% | -16.25% |
| 2022Q4 | -15.42% | -6.89% | 2020Q1 | 26.19% | -5.83% |
| 2022Q3 | -6.67% | -0.86% | 2019Q4 | -14.49% | -4.64% |
| 2022Q2 | 9.58% | -4.18% | 2019Q3 | -13.91% | -1.31% |
| 2022Q1 | -13.79% | -9.30% | 2019Q2 | -12.83% | 6.29% |
| 2021Q4 | 9.47% | -6.09% | 2019Q1 | 24.93% | 8.70% |
| 2021Q3 | -17.49% | -6.71% | 2018Q4 | 0.57% | 7.88% |
| 2021Q2 | -12.16% | 13.12% | 2018Q3 | 19.44% | 5.96% |
| 2021Q1 | -1.34% | 2.01% | 2018Q2 | -9.79% | 1.20% |
| 2020Q4 | 2.92% | 8.90% | 2018Q1 | 27.07% | -0.18% |
評論0